Aethlon Medical Announces The Conclusion Of Hemopurifier Clinical Study

Go back to Aethlon Medical Announces The Conclusion Of Hemopurifier Clinical Study
Aethlon Medical, Inc. (NASDAQ: AEMD) Delayed: 2.73 +0.03 (1.11%)
Previous Close $2.70    52 Week High $9.09 
Open $2.81    52 Week Low $4.02 
Day High $2.82    P/E N/A 
Day Low $2.69    EPS $-0.05 
Volume 37,170